Evidence map›Paper›PMID 28041267›Full record

Trial reportClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis2018

GP6 Haplotype of Missense Variants is Associated with Sticky Platelet Syndrome Manifested by Fetal Loss.

Mária Škereňová, Juraj Sokol, Kamil Biringer, Jela Ivanková, Ján Staško, Peter Kubisz, Zora Lasabová

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Polymorphisms inInternational journal of environmental research and public health · 2020
    Article
  3. Article
  4. SelectedClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mária Škereňová1 Department of Clinical Biochemistry, Jessenius Faculty of Medicine and University Hospital in Martin, Comenius University in Bratislava, Martin, Slovakia.
Juraj Sokol2 Department of Hematology and Blood Transfusion, National Center of Hemostasis and Thrombosis, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Kamil Biringer3 Department of Gynecology and Obstetrics, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Jela Ivanková2 Department of Hematology and Blood Transfusion, National Center of Hemostasis and Thrombosis, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Ján Staško2 Department of Hematology and Blood Transfusion, National Center of Hemostasis and Thrombosis, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Peter Kubisz2 Department of Hematology and Blood Transfusion, National Center of Hemostasis and Thrombosis, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Zora Lasabová5 Department of Molecular Biology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Martin, Slovakia.
Comenius University Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disequilibrium of hemostasis is central to the pathogenesis of all thromboses, and platelets are essential for primary hemostasis. The platelet membrane glycoprotein receptor is involved in the clot formation in blood; therefore, the changes in related genes could impair platelet aggregation in patients with sticky platelet syndrome (SPS). Patients with SPS who experienced fetal loss were shown to harbor a risk haplotype at GP6 locus. The aim of the study was to examine the genetic linkage of this selected risk haplotype with single nucleotide variations (SNVs) in the coding sequence of the GP6 gene in order to identify possible functional SNVs in association with SPS and fetal loss. A total of 37 patients with SPS manifested fetal loss, and 42 healthy controls were enrolled in the study. The SPS was diagnosed with platelet aggregometry. The SNVs were determined by dideoxy sequencing and high-resolution melting analysis. The missense variations were detected in patients with risk haplotype only. The association analysis showed association of the minor alleles with the SPS manifested by fetal loss as follows-rs1671152 (odds ratio [OR]: 4.667, 95% confidence interval [CI]: 1.462-14.89, P = .006), rs2304167 (OR: 5.085, 95% CI: 1.605-16.10, P = .003), and rs1654416 (OR: 5.085, 95% CI: 1.605-16.10, P = .003). Using the Expectation-Maximization (EM) algorithm, the estimated minor haplotype with predicted protein residue PEAN was significantly associated with the given phenotype (OR: 4.746, 95% CI: 1.486-15.15, P = .005). We have shown that haplotype PEAN associated with SPS and manifested by fetal loss and suggest that the mechanism involved in the action of GPVI has significant effect on GPVI-mediated signal transduction through Syk-phosphorylation.

Indexed as

Abortion, HabitualBlood Platelet DisordersGenetic Diseases, InbornHaplotypesLinkage DisequilibriumMutation, MissensePlatelet Membrane GlycoproteinsFemaleHumansPlatelet AggregationSyndromePlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIfetal lossGP6haplotypemissense variationsticky platelet syndrome

Identifiers

PMID28041267
PMCPMC6714632
OpenAlexW2574028947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.